1. In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia 
Todd R. Vogel, MD, MPH, Viktor Y. Dombrovskiy, MD, PhD, MPH, Jeffrey L. Carson, MD, Alan M. Graham, MD 
Journal of Vascular Surgery 
Volume 54, Issue 1, Pages (July 2011)
DOI: /j.jvs
Copyright © 2011 Society for Vascular Surgery Terms and Conditions

2. Fig 1
Postoperative complications in patients with tibioperoneal percutaneous transluminal angioplasty (PTA) and different indications.
Journal of Vascular Surgery  , DOI: ( /j.jvs )
Copyright © 2011 Society for Vascular Surgery Terms and Conditions

3. Fig 2
Risk factors of hospital and 30-day mortality after tibioperoneal percutaneous transluminal angioplasty (PTA). CHF, Congestive heart failure; CI, Confidence interval; OR, odds ratio.
Journal of Vascular Surgery  , DOI: ( /j.jvs )
Copyright © 2011 Society for Vascular Surgery Terms and Conditions

4. Fig 3
Reinterventions during 30 days after tibioperoneal percutaneous transluminal angioplasty (PTA).
Journal of Vascular Surgery  , DOI: ( /j.jvs )
Copyright © 2011 Society for Vascular Surgery Terms and Conditions

5. Fig 4
Thirty-day amputation rates for various indications for tibioperoneal percutaneous transluminal angioplasty (PTA).
Journal of Vascular Surgery  , DOI: ( /j.jvs )
Copyright © 2011 Society for Vascular Surgery Terms and Conditions

6. Fig 5
Risk factors for 30-day amputations after tibioperoneal percutaneous transluminal angioplasty (PTA). CHF, Congestive heart failure.
Journal of Vascular Surgery  , DOI: ( /j.jvs )
Copyright © 2011 Society for Vascular Surgery Terms and Conditions